Lingli Chen
Impact in
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 1%
- Advanced Drug Delivery Systems
Papers in
-
- RNA Interference and Gene Delivery 21
- Advanced biosensing and bioanalysis techniques 19
- DNA and Nucleic Acid Chemistry 4
- Co-authors
- Yaping Li (29 shared papers)Zhiwen Zhang (22 shared papers)Wangwen Gu (18 shared papers)Yu Gao (16 shared papers)Zhenghong Xu (9 shared papers)Qi Yin (7 shared papers)Wenjun Wang (19 shared papers)Haijun Yu (6 shared papers)
- Journals
- Biomaterials (8 papers)International Journal of Pharmaceutics (7 papers)International Journal of Biological Macromolecules (5 papers)Biomacromolecules (5 papers)Journal of Controlled Release (3 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Lingli Chen
88 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 128
- Biomaterials 854
- Pharmaceutical Science 261
- Molecular Medicine 130
- Biochemistry 109
- Molecular Biology 1.1k
Countries citing papers authored by Lingli Chen
This map shows the geographic impact of Lingli Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingli Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingli Chen more than expected).
Fields of papers citing papers by Lingli Chen
This network shows the impact of papers produced by Lingli Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingli Chen. The network helps show where Lingli Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Lingli Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 91 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 246 | |
| 2 | 2013 | 138 | |
| 3 | 2012 | 127 | |
| 4 | 2014 | 124 | |
| 5 | 2008 | 119 | |
| 6 | 2014 | 108 | |
| 7 | 2020 | 106 | |
| 8 | 2016 | 98 | |
| 9 | 2014 | 97 | |
| 10 | 2015 | 72 | |
| 11 | 2009 | 69 | |
| 12 | 2008 | 67 | |
| 13 | 2009 | 62 | |
| 14 | 2021 | 58 | |
| 15 | 2006 | 57 | |
| 16 | 2010 | 53 | |
| 17 | 2012 | 51 | |
| 18 | 2008 | 49 | |
| 19 | 2011 | 49 | |
| 20 | 2020 | 44 |
About Lingli Chen
Lingli Chen is a scholar working on Molecular Biology, Plant Science, Genetics, Biomaterials and Immunology, having authored 91 papers that have together received 2.9k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (21 papers), Advanced biosensing and bioanalysis techniques (19 papers), Nanoparticle-Based Drug Delivery (9 papers), Virus-based gene therapy research (8 papers), COVID-19 Clinical Research Studies (4 papers), Proteins in Food Systems (4 papers), DNA and Nucleic Acid Chemistry (4 papers) and Biosensors and Analytical Detection (3 papers). The work is most often cited by research in Biomaterials (854 citations), Pharmaceutical Science (261 citations), Molecular Medicine (130 citations), Biochemistry (109 citations) and Molecular Biology (1.1k citations). Lingli Chen has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Yaping Li, Zhiwen Zhang, Wangwen Gu, Yu Gao, Zhenghong Xu, Qi Yin, Wenjun Wang, Haijun Yu, Rui Yang and Liping Lin. Their work appears in journals such as Biomaterials, International Journal of Pharmaceutics, International Journal of Biological Macromolecules, Biomacromolecules and Journal of Controlled Release.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.